| Literature DB >> 30021595 |
Mara Lelii1, Laura Senatore1, Ilaria Amodeo2, Raffaella Pinzani1, Sara Torretta3, Stefano Fiori4, Paola Marchisio1, Samantha Bosis5.
Abstract
BACKGROUND: Kikuchi-Fujimoto disease is a rare, idiopathic and generally self-limiting cause of lymphadenitis of unknow etiology with a low recurrence rate. The typical clinical signs are cervical lymphadenopathy, fever, and symptoms of respiratory infection, and less frequently chills, night sweats, arthralgia, rash, and weight loss. CASEEntities:
Keywords: HLH; Hemophagocytic lymphohistiocytosis; Kikuchi-Fujimoto disease; Lymphadenitis; Persistent fever; Recurrent lymphadenitis; Relapsing Kikuchi-Fujimoto disease
Mesh:
Year: 2018 PMID: 30021595 PMCID: PMC6052688 DOI: 10.1186/s13052-018-0522-9
Source DB: PubMed Journal: Ital J Pediatr ISSN: 1720-8424 Impact factor: 2.638
Fig. 1Case 1, 3rd level laterocervical lesion, including a lymphnode (1 cm in diameter) and several small tissue fragments (0.3 cm the largest) Lymph node (hematoxilin-eosin, 2×). The circle indicates the only small subcapsular necrotic focus. Inset shows a 20× magnification of the focus: note karyorrhectic debris and several large immunoblastic cells
Fig. 2Detail of Case 1, tissue fragment (hematoxilin-eosin, 20×). Plasmacytoid histiocytes (arrows) and large immunoblastic cells in a necrotic and karyorrhectic background, devoid of granulocytes. Inset shows a CD3 immunohistochemical stain (20×), demonstrating that most of the large cells have a T-cell phenotype
Fig. 3Case 2, a submandibular lymphnode (1,5 in diameter, hematoxilin-eosin, 2×). The circle indicates plurifocal subcapsular necrotic foci. Inset shows a 20× magnification of the largest focus: it was composed of fibrinoid material, karyorrhectic debris and several large immunoblastic cells
| 2012 | In Sri Lanka diagnosis of KFD |
| January 2017 | Admission to our hospital for fever of 4 days duration and bilateral cervical lymphadenopathy |
| Ten day after the admission | Lymph node biopsy was performed |
| Fifteen days after the admission | Stop of the fever |
| Twenty-two days after the admission | Discharged |
| Ten days after discharged | Follow up visit |
| April 2017 | Admission to our hospital and start of cefotaxime therapy |
| Day after admission | Resolution of the fever |
| Six days after admission | Reappearance of fever, enlargement of the lymphadenopathies and worsening of the blood exams |
| Eleven days after admission | Cefotaxime was replaced by piperacillin/tazobactam (150 mg/kg/day) and vancomycin (40 mg/kg/day) with regression of fever |
| Twenty days after admission | The fever returned and progressive enlargement of the previous lymphadenopathies. An excisional cervical lymph node was performed. |
| Twenty-eight after admission | Diagnosis of initial HLH |
| A month after the admission | Diagnosis of posterior reversible encephalopathy syndrome (PRES) |
| A month and five days after the admission | Discharged |
| Ten days after discharged | Follow-up visit |